3 timer på dag 1, efterfulgt af gemcitabin (1250 mg/ m2) indgivet intravenøst over 30 minutter på dag 1 og 8 i hver 21 dages cyklus.
Breast cancer Combination use Gemcitabine in combination with paclitaxel is recommended using paclitaxel (175 mg/m2) administered on Day 1 over approximately 3-hours as an intravenous infusion, followed by gemcitabine (1250 mg/m2) as a 30-minute intravenous infusion on Days 1 and 8 of each 21-day cycle.